Skip Navigation LinksHome > December 2009 - Volume 32 - Issue 6 > Efficacy and Safety of Transarterial Chemoembolization in Re...
American Journal of Clinical Oncology:
doi: 10.1097/COC.0b013e3181967da0
Original Article: Gastointestinal

Efficacy and Safety of Transarterial Chemoembolization in Recurrent Hepatocellular Carcinoma After Curative Surgical Resection

Choi, Jong Won MD*†; Park, Jun Yong MD*†‡; Ahn, Sang Hoon MD*†‡; Yoon, Ki Tae MD*†; Ko, Heung-kyu MD§; Lee, Do Yun MD§; Lee, Jong Tae MD§; Kim, Kyung Sik MD¶; Choi, Jin Sub MD¶; Han, Kwang-Hyub MD*†‡; Chon, Chae Yoon MD*†‡; Kim, Do Young MD*†‡

Collapse Box

Abstract

Objectives: To evaluate the efficacy and safety of transarterial chemoembolization (TACE) for recurrent hepatocellular carcinoma (HCC) after curative resection and to examine the factors associated with the prognosis in a single center.

Methods: Between January 1995 and July 2006, 169 patients who had undergone curative resection were diagnosed with recurrent HCC. Of these, 114 patients underwent TACE as first-line therapy and were followed until July 2007.

Results: At the time of resection, the mean tumor size was 4.8 ± 2.9 cm, and 96 (84.2%) patients had a single tumor. Single nodular recurrence was observed in 53 (46.5%) patients. The mean size of the recurrent HCC was 2.1 ±1.2 cm. The disease-free survival after TACE was 46.0%, 16.7%, and 13.4% at 1, 2, and 3 years, respectively. The overall survival after TACE was 77.8%, 53.6%, and 31.6% at 1, 3, and 5 years, respectively. Cox regression analysis revealed that the Edmonson grade and time to recurrence (>6 months) independently affected the disease-free survival (both P < 0.05). The time to recurrence (>6 months) and tumor-node-metastasis stage were associated with overall survival (both P < 0.05). Only 1 lethal complication (biliary sepsis) occurred after TACE.

Conclusions: TACE seems to be a safe, effective treatment for recurrent HCC after curative resection.

© 2009 Lippincott Williams & Wilkins, Inc.

Login

Article Tools

Share

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.

Connect With Us

Twitter
twitter.com/AJCOonline

For additional oncology content, visit LWW Oncology Journals on Facebook.